Ion Beam Applications SA (ENXTBR:IBAB) signed an agreement to acquire all the assets of Radcal Corporation on February 8, 2024. Through this acquisition, IBA will further strengthen its Medical Imaging Quality Assurance offering and its presence in the US market. Closing is expected on February 29, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.86 EUR | -0.77% | -3.02% | +11.44% |
Mar. 21 | Ion Beam Applications SA to Recommend Dividend for 2023 | CI |
Mar. 21 | Transcript : Ion Beam Applications SA, 2023 Earnings Call, Mar 21, 2024 |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+11.44% | 400M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- IBAB Stock
- News Ion Beam Applications, SA
- Ion Beam Applications SA signed an agreement to acquire all the assets of Radcal Corporation.